Which has better valuation and earnings, GDRX or ANDG?

GoodRx has higher earnings, but lower revenue than Andersen Group. GoodRx is trading at a lower price-to-earnings ratio than Andersen Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.29 $30.44M $0.06 50.17 Andersen Group $838.69M 5.76 -$2.32M $0.17 251.71

Does the media refer more to GDRX or ANDG?

In the previous week, GoodRx had 1 more articles in the media than Andersen Group. MarketBeat recorded 5 mentions for GoodRx and 4 mentions for Andersen Group. GoodRx's average media sentiment score of 0.77 beat Andersen Group's score of 0.69 indicating that GoodRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Andersen Group 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, FOUR or GDRX?

Shift4 Payments has higher revenue and earnings than GoodRx. GoodRx is trading at a lower price-to-earnings ratio than Shift4 Payments, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Shift4 Payments $4.18B 0.95 $119M $0.84 59.55 GoodRx $796.85M 1.29 $30.44M $0.06 50.17

Is FOUR or GDRX more profitable?

Shift4 Payments has a net margin of 2.63% compared to GoodRx's net margin of 2.61%. Shift4 Payments' return on equity of 33.55% beat GoodRx's return on equity. Company Net Margins Return on Equity Return on Assets Shift4 Payments 2.63% 33.55% 5.01% GoodRx 2.61% 7.90% 3.23%

Does the media favor FOUR or GDRX?

In the previous week, Shift4 Payments had 1 more articles in the media than GoodRx. MarketBeat recorded 6 mentions for Shift4 Payments and 5 mentions for GoodRx. Shift4 Payments' average media sentiment score of 0.96 beat GoodRx's score of 0.77 indicating that Shift4 Payments is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shift4 Payments 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, YY or GDRX?

JOYY has higher revenue and earnings than GoodRx. JOYY is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio JOYY $2.24B 1.68 $301.82M -$3.10 N/A GoodRx $796.85M 1.29 $30.44M $0.06 50.17

Is YY or GDRX more profitable?

JOYY has a net margin of 9.02% compared to GoodRx's net margin of 2.61%. GoodRx's return on equity of 7.90% beat JOYY's return on equity. Company Net Margins Return on Equity Return on Assets JOYY 9.02% 4.64% 2.96% GoodRx 2.61% 7.90% 3.23%

Does the media favor YY or GDRX?

In the previous week, GoodRx had 4 more articles in the media than JOYY. MarketBeat recorded 5 mentions for GoodRx and 1 mentions for JOYY. GoodRx's average media sentiment score of 0.77 beat JOYY's score of 0.00 indicating that GoodRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment JOYY 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GoodRx 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate WPP or GDRX?

GoodRx has a consensus price target of $3.81, indicating a potential upside of 26.66%. Given GoodRx's stronger consensus rating and higher possible upside, analysts clearly believe GoodRx is more favorable than WPP. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score WPP 2 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00 GoodRx 3 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.13

Which has preferable valuation and earnings, WPP or GDRX?

GoodRx has lower revenue, but higher earnings than WPP. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio WPP $17.87B 0.22 -$283.52M N/A N/A GoodRx $796.85M 1.29 $30.44M $0.06 50.17

Is WPP or GDRX more profitable?

GoodRx has a net margin of 2.61% compared to WPP's net margin of 0.00%. GoodRx's return on equity of 7.90% beat WPP's return on equity. Company Net Margins Return on Equity Return on Assets WPP N/A N/A N/A GoodRx 2.61% 7.90% 3.23%

Does the media favor WPP or GDRX?

In the previous week, WPP and WPP both had 5 articles in the media. GoodRx's average media sentiment score of 0.77 beat WPP's score of 0.68 indicating that GoodRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment WPP 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, GDRX or FA?

First Advantage has higher revenue and earnings than GoodRx. GoodRx is trading at a lower price-to-earnings ratio than First Advantage, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.29 $30.44M $0.06 50.17 First Advantage $1.61B 2.26 $37.29M $0.04 528.75

Does the media refer more to GDRX or FA?

In the previous week, GoodRx and GoodRx both had 5 articles in the media. First Advantage's average media sentiment score of 1.19 beat GoodRx's score of 0.77 indicating that First Advantage is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive First Advantage 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

GoodRx (GDRX) Competitors

$3.01 -0.03 (-0.99%)

Closing price 07/14/2026 04:00 PM Eastern

Extended Trading

$3.01 +0.00 (+0.13%)

As of 07/14/2026 07:59 PM Eastern

Compare

GDRX vs. ANDG, FOUR, YY, WPP, and FA

Should you buy GoodRx stock or one of its competitors? MarketBeat compares GoodRx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with GoodRx include Andersen Group (ANDG), Shift4 Payments (FOUR), JOYY (YY), WPP (WPP), and First Advantage (FA). These companies are all part of the "business services" industry.

How does GoodRx compare to Andersen Group?

GoodRx (NASDAQ:GDRX) and Andersen Group (NYSE:ANDG) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

63.8% of GoodRx shares are owned by institutional investors. 5.9% of GoodRx shares are owned by insiders. Comparatively, 13.0% of Andersen Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

GoodRx has a net margin of 2.61% compared to Andersen Group's net margin of 0.00%. GoodRx's return on equity of 7.90% beat Andersen Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.61%	7.90%	3.23%
Andersen Group	N/A	N/A	N/A

GoodRx has higher earnings, but lower revenue than Andersen Group. GoodRx is trading at a lower price-to-earnings ratio than Andersen Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.29	$30.44M	$0.06	50.17
Andersen Group	$838.69M	5.76	-$2.32M	$0.17	251.71

In the previous week, GoodRx had 1 more articles in the media than Andersen Group. MarketBeat recorded 5 mentions for GoodRx and 4 mentions for Andersen Group. GoodRx's average media sentiment score of 0.77 beat Andersen Group's score of 0.69 indicating that GoodRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Andersen Group	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

GoodRx currently has a consensus target price of $3.81, indicating a potential upside of 26.66%. Andersen Group has a consensus target price of $39.00, indicating a potential downside of 8.86%. Given GoodRx's higher possible upside, equities research analysts clearly believe GoodRx is more favorable than Andersen Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13
Andersen Group	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56

Summary

GoodRx beats Andersen Group on 9 of the 16 factors compared between the two stocks.

How does GoodRx compare to Shift4 Payments?

Shift4 Payments (NYSE:FOUR) and GoodRx (NASDAQ:GDRX) are both business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

Shift4 Payments has higher revenue and earnings than GoodRx. GoodRx is trading at a lower price-to-earnings ratio than Shift4 Payments, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shift4 Payments	$4.18B	0.95	$119M	$0.84	59.55
GoodRx	$796.85M	1.29	$30.44M	$0.06	50.17

Shift4 Payments has a net margin of 2.63% compared to GoodRx's net margin of 2.61%. Shift4 Payments' return on equity of 33.55% beat GoodRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shift4 Payments	2.63%	33.55%	5.01%
GoodRx	2.61%	7.90%	3.23%

Shift4 Payments currently has a consensus target price of $68.24, suggesting a potential upside of 36.42%. GoodRx has a consensus target price of $3.81, suggesting a potential upside of 26.66%. Given Shift4 Payments' stronger consensus rating and higher possible upside, research analysts clearly believe Shift4 Payments is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shift4 Payments	1 Sell rating(s)	12 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.39
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13

Shift4 Payments has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market. Comparatively, GoodRx has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

98.9% of Shift4 Payments shares are held by institutional investors. Comparatively, 63.8% of GoodRx shares are held by institutional investors. 1.5% of Shift4 Payments shares are held by company insiders. Comparatively, 5.9% of GoodRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Shift4 Payments had 1 more articles in the media than GoodRx. MarketBeat recorded 6 mentions for Shift4 Payments and 5 mentions for GoodRx. Shift4 Payments' average media sentiment score of 0.96 beat GoodRx's score of 0.77 indicating that Shift4 Payments is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shift4 Payments	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GoodRx	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Shift4 Payments beats GoodRx on 13 of the 16 factors compared between the two stocks.

How does GoodRx compare to JOYY?

JOYY (NASDAQ:YY) and GoodRx (NASDAQ:GDRX) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.

In the previous week, GoodRx had 4 more articles in the media than JOYY. MarketBeat recorded 5 mentions for GoodRx and 1 mentions for JOYY. GoodRx's average media sentiment score of 0.77 beat JOYY's score of 0.00 indicating that GoodRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
JOYY	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
GoodRx	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

JOYY has higher revenue and earnings than GoodRx. JOYY is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
JOYY	$2.24B	1.68	$301.82M	-$3.10	N/A
GoodRx	$796.85M	1.29	$30.44M	$0.06	50.17

36.8% of JOYY shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 43.0% of JOYY shares are owned by company insiders. Comparatively, 5.9% of GoodRx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

JOYY has a net margin of 9.02% compared to GoodRx's net margin of 2.61%. GoodRx's return on equity of 7.90% beat JOYY's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
JOYY	9.02%	4.64%	2.96%
GoodRx	2.61%	7.90%	3.23%

JOYY has a beta of 0.21, indicating that its stock price is 79% less volatile than the broader market. Comparatively, GoodRx has a beta of 1.6, indicating that its stock price is 60% more volatile than the broader market.

JOYY presently has a consensus target price of $66.00, indicating a potential downside of 5.38%. GoodRx has a consensus target price of $3.81, indicating a potential upside of 26.66%. Given GoodRx's higher probable upside, analysts plainly believe GoodRx is more favorable than JOYY.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
JOYY	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13

Summary

GoodRx beats JOYY on 10 of the 16 factors compared between the two stocks.

How does GoodRx compare to WPP?

WPP (NYSE:WPP) and GoodRx (NASDAQ:GDRX) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

GoodRx has a net margin of 2.61% compared to WPP's net margin of 0.00%. GoodRx's return on equity of 7.90% beat WPP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
WPP	N/A	N/A	N/A
GoodRx	2.61%	7.90%	3.23%

WPP has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market. Comparatively, GoodRx has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market.

In the previous week, WPP and WPP both had 5 articles in the media. GoodRx's average media sentiment score of 0.77 beat WPP's score of 0.68 indicating that GoodRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
WPP	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GoodRx	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

GoodRx has lower revenue, but higher earnings than WPP.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WPP	$17.87B	0.22	-$283.52M	N/A	N/A
GoodRx	$796.85M	1.29	$30.44M	$0.06	50.17

GoodRx has a consensus price target of $3.81, indicating a potential upside of 26.66%. Given GoodRx's stronger consensus rating and higher possible upside, analysts clearly believe GoodRx is more favorable than WPP.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WPP	2 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13

4.3% of WPP shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 1.0% of WPP shares are owned by company insiders. Comparatively, 5.9% of GoodRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

GoodRx beats WPP on 12 of the 13 factors compared between the two stocks.

How does GoodRx compare to First Advantage?

GoodRx (NASDAQ:GDRX) and First Advantage (NYSE:FA) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, dividends, valuation and earnings.

GoodRx currently has a consensus target price of $3.81, suggesting a potential upside of 26.66%. First Advantage has a consensus target price of $18.50, suggesting a potential downside of 12.53%. Given GoodRx's higher probable upside, equities research analysts plainly believe GoodRx is more favorable than First Advantage.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13
First Advantage	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, GoodRx and GoodRx both had 5 articles in the media. First Advantage's average media sentiment score of 1.19 beat GoodRx's score of 0.77 indicating that First Advantage is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
First Advantage	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

First Advantage has higher revenue and earnings than GoodRx. GoodRx is trading at a lower price-to-earnings ratio than First Advantage, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.29	$30.44M	$0.06	50.17
First Advantage	$1.61B	2.26	$37.29M	$0.04	528.75

GoodRx has a beta of 1.6, meaning that its share price is 60% more volatile than the broader market. Comparatively, First Advantage has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market.

GoodRx has a net margin of 2.61% compared to First Advantage's net margin of 0.65%. First Advantage's return on equity of 13.16% beat GoodRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.61%	7.90%	3.23%
First Advantage	0.65%	13.16%	7.33%

63.8% of GoodRx shares are held by institutional investors. Comparatively, 94.9% of First Advantage shares are held by institutional investors. 5.9% of GoodRx shares are held by insiders. Comparatively, 4.4% of First Advantage shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

First Advantage beats GoodRx on 9 of the 15 factors compared between the two stocks.

Get GoodRx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GDRX vs. The Competition

Export

Metric	GoodRx	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.04B	$9.53B	$6.85B	$12.44B
Dividend Yield	N/A	1.63%	2.68%	8.43%
P/E Ratio	50.18	25.39	27.04	24.38
Price / Sales	1.29	17.88	524.25	92.59
Price / Cash	7.60	112.66	48.59	59.36
Price / Book	1.66	6.04	10.80	6.33
Net Income	$30.44M	$177.20M	$3.59B	$331.02M
7 Day Performance	1.69%	0.02%	-1.46%	-0.33%
1 Month Performance	10.26%	6.99%	2.82%	-1.29%
1 Year Performance	-36.63%	13.89%	28.59%	21.30%

GoodRx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GDRX GoodRx	3.9519 of 5 stars	$3.01 -1.0%	$3.81 +26.7%	-37.7%	$1.04B	$796.85M	50.18	950
ANDG Andersen Group	2.2006 of 5 stars	$37.95 +4.4%	$39.00 +2.8%	N/A	$4.11B	$838.69M	N/A	2,300
FOUR Shift4 Payments	4.813 of 5 stars	$51.38 +0.1%	$68.29 +32.9%	-51.5%	$4.07B	$4.18B	61.17	6,300
YY JOYY	1.3836 of 5 stars	$67.26 +0.5%	$66.00 -1.9%	+30.0%	$3.62B	$2.24B	20.32	7,450
WPP WPP	2.079 of 5 stars	$17.36 +5.0%	N/A	-34.4%	$3.57B	$17.87B	N/A	98,655	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GDRX) was last updated on 7/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GoodRx (GDRX) Competitors

GDRX vs. ANDG, FOUR, YY, WPP, and FA

How does GoodRx compare to Andersen Group?

Summary

How does GoodRx compare to Shift4 Payments?

Summary

How does GoodRx compare to JOYY?

Summary

How does GoodRx compare to WPP?

Summary

How does GoodRx compare to First Advantage?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GDRX vs. The Competition

GoodRx Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

GoodRx (GDRX) Competitors

GDRX vs. ANDG, FOUR, YY, WPP, and FA

How does GoodRx compare to Andersen Group?

Do institutionals & insiders believe in GDRX or ANDG?

Is GDRX or ANDG more profitable?

Which has better valuation and earnings, GDRX or ANDG?

Does the media refer more to GDRX or ANDG?

Do analysts rate GDRX or ANDG?

Summary

How does GoodRx compare to Shift4 Payments?

Which has stronger earnings and valuation, FOUR or GDRX?

Is FOUR or GDRX more profitable?

Do analysts recommend FOUR or GDRX?

Which has more risk & volatility, FOUR or GDRX?

Do institutionals and insiders have more ownership in FOUR or GDRX?

Does the media favor FOUR or GDRX?

Summary

How does GoodRx compare to JOYY?

Does the media favor YY or GDRX?

Which has higher earnings and valuation, YY or GDRX?

Do insiders & institutionals have more ownership in YY or GDRX?

Is YY or GDRX more profitable?

Which has more volatility & risk, YY or GDRX?

Do analysts rate YY or GDRX?

Summary

How does GoodRx compare to WPP?

Is WPP or GDRX more profitable?

Which has more risk and volatility, WPP or GDRX?

Does the media favor WPP or GDRX?

Which has preferable valuation and earnings, WPP or GDRX?

Do analysts rate WPP or GDRX?

Do insiders and institutionals have more ownership in WPP or GDRX?

Summary

How does GoodRx compare to First Advantage?

Do analysts prefer GDRX or FA?

Does the media refer more to GDRX or FA?

Which has better valuation and earnings, GDRX or FA?

Which has more volatility & risk, GDRX or FA?

Is GDRX or FA more profitable?

Do institutionals & insiders have more ownership in GDRX or FA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GDRX vs. The Competition

GoodRx Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools